Biolargo Inc (BLGO) 0.4012 $BLGO Breakthrough Technology

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biolargo Inc (BLGO) 0.4012 $BLGO

Breakthrough Technology To Help Poultry Industry Meet Tough New Food Safety Regulations
ACCESSWIRE - Tue Jul 05, 8:34AM CDT
REDONDO BEACH, CA / ACCESSWIRE / July 5, 2016 / In an effort to reduce foodborne illness, the U.S. Department of Agriculture's Food Safety and Inspection Service, FSIS, announced new federal standards to reduce Salmonella and Campylobacter in ground chicken and turkey products, as well as in raw chicken breasts, legs, and wings.
WFM: 33.58 (+0.30), SAFM: 89.91 (+0.56), SYY: 51.59 (+0.40), HABT: 16.33 (+0.07), TSN: 68.92 (+1.26), HRL: 36.61 (+0.17), UNFI: 48.84 (+1.40), PPC: 25.79 (-0.03), USFD: 25.08 (+0.06), MCD: 121.31 (+0.39), LOCO: 13.16 (+0.31), TAST: 12.36 (+0.27)

BioLargo's Commercialization Partner Receives EPA Approval
Marketwire Canada - Tue May 31, 11:52AM CDT
SANTA ANA, CA--(Marketwired - May 31, 2016) - BioLargo, Inc. (OTCQB: BLGO) announced today that its licensee, Clarion Water, had received approval from the United States Environmental Protection Agency (EPA) for its aqueous iodine product, IoMax™, for sanitation of poultry drinking water. IoMax™ is supplied through the patented iSAN™ delivery system that accurately doses aqueous iodine into water systems. The iSAN system is licensed by Clarion from BioLargo and its joint venture partner Peter Holdings Ltd. of Australia.

Unsurpassed Performance Wins Customers for BioLargo's Breakthrough Industrial Odor Control Products
ACCESSWIRE - Tue May 24, 7:32AM CDT
Odor control is a top priority for any industry handling decomposing material that naturally stinks Odor control for big industry is big business Commonly used masking fragrances, chlorine compounds, and enzyme based odor products help mask or reduce malodors, but do not eliminate them BioLargo's CupriDyne® Clean is sustainable, safe, easy to use and it effectively breaks down and eliminates malodors like Hydrogen Sulfide, Amines, Mercaptans and Sulfur Dioxide on contact rendering them harmless, odorless, and non-volatile
CVA: 16.61 (+0.07), SRCL: 104.70 (+2.64), AWK: 83.36 (+0.78), RSG: 52.56 (+0.47), TSN: 68.92 (+1.26), DAR: 14.91 (+0.28), WM: 67.61 (+0.32)

BioLargo's Breakthrough Water Treatment System Marching to Commercialization in $360 Billion Market
ACCESSWIRE - Wed May 18, 7:31AM CDT
REDONDO BEACH, CA / ACCESSWIRE / May 18, 2016 / Water is big business and it's growing faster than the U.S. and global economies that continue to struggle at rates below 3%. GE (NYSE: GE) claims the world's water market is worth $360 billion annually and is growing at a rate of six percent, while Bank of America (NYSE: BAC) puts the number closer to $500 Billion and projects a growth rate of 6-7%. By all accounts, the industry is big and the need for water treatment in the U.S. alone spans over 54,000 municipal water systems, plus thousands of large private industrial operations requiring water treatment for a plethora of industries and uses.
NOG: 4.55 (+0.21), GE: 32.20 (+0.38), NM: 0.88 (+0.06), BAC: 13.17 (+0.16), SWN: 12.87 (+0.54), DRYS: 0.46 (unch)

BioLargo Concludes Successful Customer Trials and New Sales for CupriDyne Clean Industrial Odor Control
Marketwired - Wed May 11, 12:48PM CDT
SANTA ANA, CA--(Marketwired - May 11, 2016) - BioLargo, Inc. (OTCQB: BLGO) announced today that it had successfully concluded a series of free trials with industry leading corporations and municipalities to introduce its breakthrough product CupriDyne Clean to industry. "We've outperformed every product that we've come across in the market and our pricing has been well received," stated BioLargo president Dennis Calvert. The company is expanding its sales efforts and more trials are underway.

BioLargo Announces CupriDyne Clean
Marketwired - Mon May 02, 9:52AM CDT
BioLargo, Inc. (OTCQB: BLGO) today announced the availability of "CupriDyne Clean" All-Purpose Free Iodine Wash and Industrial Odor Eliminators for unsurpassed odor elimination (www.CupriDyne.com). Available in 1 gallon, 20 gallon, and 55 gallon concentrates either fragranced or fragrance-free for industrial users. CupriDyne Clean oxidizes odorous compounds and is ideal for waste transfer stations, composting facilities, landfill operations, sewage plants and lift stations, food processing plants and animal enclosures. Dispensed through misting systems, portable sprayers and water trucks, it is safe and effective on a host of surfaces including soils, metals, concrete and asphalt docks, floors, walls, feed and water receptacles, waste receptacles, tanks, bins, liners and dumpsters.

BioLargo's AOS Filter Starts Prototype Development Phase With Team at Northern Alberta Institute of Technology
Marketwired - Tue Apr 12, 8:50AM CDT
BioLargo, Inc. (OTCQB: BLGO), inventor of patented iodine based disinfection technologies, announced that its Canadian subsidiary BioLargo Water, Inc. has started a prototype development project for its AOS Filter technology.

Medical Products Companies Tap Into $50 Billion U.S. Government GSA Supply Program
ACCESSWIRE - Wed Mar 16, 7:30AM CDT
REDONDO BEACH, CA / ACCESSWIRE / March 16, 2016 / Last week, BioLargo, Inc. (OTC: BLGO), best known for the AOS Filter that has demonstrated the highest impact and lowest cost of any known water treatment technology, announced that the U.S. government had awarded them a five-year General Services Administration and VA Schedule supply contract, under schedule 65IIA for medical equipment and supplies. This contract award is significant because it opens up an important selling channel for the company's current odor and moisture control products as well as future products that will include its Advanced Wound Care Products when they are approved by the FDA. The GSA Schedules program is the premier acquisition vehicle in government with approximately $50 Billion a year in spending for a broad spectrum of products.
DSCI: 4.22 (+0.15), SNN: 34.44 (+0.37), VCEL: 2.22 (+0.05), ALQA: 1.19 (-0.03)

BioLargo's Odor-No-More Products Approved to Sell Through GSA Advantage and VA Schedule
Marketwired - Mon Mar 07, 12:05PM CST
BioLargo, Inc. (OTCQB: BLGO) announced today that two product lines (consisting of 9 SKUs) of its Nature's Best Science products were awarded a five year U.S. General Services Administration (GSA) supply contract, under schedule 65IIA for medical equipment and supplies. The award opens up an important selling channel for the company's current and future products.

New Food Safety Solutions Can Reduce Outbreak Risk For Chipotle And Fast Food Chains
ACCESSWIRE - Tue Feb 02, 7:30AM CST
REDONDO BEACH, CA / ACCESSWIRE / February 2, 2016 / Chipotle (NYSE: CMG) has been prominent in the news for the past several months with a series of E.coli, listeria and norovirus outbreaks that have sickened close to 500 patrons across 13 states. News of the outbreaks and restaurant closures sent thousands of investors reeling with losses totaling billions of dollars. Chiptole's outbreaks are a sobering reminder of how risky the food business can be when it comes to food safety.
CMG: 399.71 (+8.93), HABT: 16.33 (+0.07), LOCO: 13.16 (+0.31), TAST: 12.36 (+0.27)

BioLargo Closes Financing To Advance Its Novel Wound Care Products
ACCESSWIRE - Wed Jan 20, 7:00AM CST
REDONDO BEACH, CA / ACCESSWIRE / January 20, 2016 / BioLargo, Inc. (OTC: BLGO) recently announced that its subsidiary, Clyra Medical Technologies, secured a $5.75 million financing package for Its Advanced Wound Care Products. Cash of $750,000 is earmarked for FDA Application and approval, and a $5 million line of credit is dedicated to commercialization once FDA approval is complete.
DSCI: 4.22 (+0.15), SNN: 34.44 (+0.37), VCEL: 2.22 (+0.05), OSIR: 5.03 (+0.17)

BioLargo Secures Financing for Its Advanced Wound Care Products Targeting FDA Application, Approval and Commercialization Through Its Subsidiary Clyra Medical Technologies
Marketwired - Wed Jan 06, 2:27PM CST
BioLargo, Inc. (OTCQB: BLGO) subsidiary Clyra Medical Technologies, Inc. has successfully concluded a financing from Sanatio Capital LLC for $750,000 in equity and a forward commitment to provide a $5,000,000 operating line of credit, to support the FDA approval and commercial launch of Clyra's advanced wound care products.

Frost & Sullivan Applauds BioLargo's Innovative, Iodine-based Water Treatment Technology in the North American Market
PR Newswire - Mon Jan 04, 8:00AM CST
Based on its recent analysis of the water treatment market, Frost & Sullivan recognizes BioLargo Water, Inc. [a wholly-owned subsidiary of BioLargo, Inc. Symbol: BLGO) with the 2015 North American Frost & Sullivan Award for New Product Innovation. BioLargo Water, Inc.'s Advanced Oxidation System (AOS) Filter is a low-cost, high-impact and sustainable clean water technology that has captured the interest of academia, governments, and the industry. With applications ranging from food and agriculture to ballast water treatment, the AOS Filter demonstrates industry-leading decontamination and disinfection capabilities and is poised for a scale-up and successful commercialization in the tertiary and advanced waste water treatment (WWT) market.

StockNewsNow.com Publishes New SNNLive Video Interview With BioLargo, Inc.
Marketwired - Wed Dec 23, 8:00AM CST
StockNewsNow.com, The Official MicroCap News Source(TM), today published an SNNLive Video Interview with Dennis Calvert, President and CEO of BioLargo, Inc. (OTCQB: BLGO), developing technology-based products that are looking to solve some of the world's most important problems that threaten water, food, agriculture, healthcare and energy, according to the Company's website (see here: www.BioLargo.com). The video interview was recorded at the LD Micro "Main Event" on December 3rd, 2015 in Bel Air, CA.

BioLargo Receives Additional Support to Scale Up Its AOS Filter
Marketwired - Mon Dec 14, 9:14AM CST
BioLargo, Inc.'s (OTCQB: BLGO) Canadian subsidiary (www.BioLargoWater.ca) will receive up to C$220,000 in financial support and advisory services from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) to continue advancing its AOS Filter (Advanced Oxidation System). The support fuels a pivotal moment in the development of the AOS Filter, enabling BioLargo's research and development team to expand the scope of the technology's decontamination and disinfection capabilities (focusing on bacterial spores and capsid viruses), as well as to demonstrate its abilities for viable large-scale deployment and commercial implementation in industries such as livestock processing. The contribution from NRC-IRAP, the fourth received by BioLargo Water, provides funding for 80% of supported salary costs and 50% of supported contractor fees.

BioLargo Named Technology Innovation Leader in the Water Treatment Market by Global Research Company Frost & Sullivan
Marketwired - Wed Dec 02, 5:42PM CST
BioLargo, Inc. (OTCQB: BLGO) -- BioLargo's subsidiary BioLargo Water, Inc. has been awarded the prestigious New Product Innovation Award for the Water Treatment Industry - North America by Frost & Sullivan. Frost & Sullivan has a global team of analysts and consultants continuously researching a wide range of markets and companies to identify those that consistently pursue or invest in new technologies, enabling them to serve their customers more effectively and grow at above-industry average. This involves extensive primary and secondary research across the entire value chain of specific products.

BioLargo's AOS Filter Poised to Create Windfall for Oil & Gas Producers
ACCESSWIRE - Wed Nov 18, 9:51AM CST
REDONDO BEACH, CA / ACCESSWIRE / November 18, 2015 / When oil was trading at 80 to 100 dollars per barrel, there was plenty of room to pay for the high cost of water management for fracking operations, however, now that the price of oil is falling and flirting with 40 dollars per barrel, profit margins are upside down, and continuing high water management costs are exacerbating widespread industry losses.
LGCY: 1.70 (+0.05), HK: 0.44 (unch), GDP: 0.16 (-0.04), SWN: 12.87 (+0.54)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 337

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 130

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 148

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 121

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 197

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 201

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 152

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading

Top 5 Most Recently Viewed Articles

Reeflex Solutions Secures Major Contract with Iron Horse Energy

Updated Category News Views 121

Reeflex Solutions Inc. Announces Major Contract Win Reeflex Solutions Inc. (TSXV: RFX) has made headlines recently by securing a substantial contract valued at $3.4 million. This contract was awarded to Ranglar Manufacturing, a branch of Reeflex's subsidiary, Coil Solutions Inc. (CSI), recognizing their engineering expertise in the oil and gas sector. Custom Engineered...

Continue Reading
Oracle's Strong Options Activity Reflects Investor Confidence

Updated Category News Views 190

Oracle's Options Activity Signals Bullish Investor Sentiment Investors are showing a noteworthy bullish outlook regarding Oracle, as evidenced by the latest options trading patterns. Large players in the market, often referred to as whales, have been executing a series of trades that suggest heightened confidence. Analyzing the recent options history for Oracle ORCL, we...

Continue Reading
Unlocking AI Power for Everyone: A New Era in Computing

Updated Category News Views 133

Democratizing AI: A New Approach to Computing Power For many years, artificial intelligence computing was a privilege reserved for major tech companies, elite research institutions, and those with extensive resources. However, LCPC AI is changing this narrative by making AI computing power accessible to individuals across the globe through its innovative cloud-based...

Continue Reading
Brødrene A&O Johansen A/S Acquires New Growth Opportunities

Updated Category News Views 122

Q2 2025 Financial Overview The recent interim report for the second quarter of 2025 has illuminated the impressive strides made by Brødrene A&O Johansen A/S. During this quarter, the company achieved remarkable overall revenue of DKK 1,497m, showcasing their successful strategies in an increasingly competitive market. Performance Highlights The financial highlights...

Continue Reading
JCDecaux Implements Share Buy-Back for Investor Confidence Boost

Updated Category News Views 226

JCDecaux Initiates Share Buy-Back Programme In an impressive move aimed at strengthening shareholder value, JCDecaux SE (Euronext Paris: DEC), recognized globally as the leading outdoor advertising firm, has declared a new share buy-back plan enabling the repurchase of up to 1.5 million shares. This initiative underscores the company's commitment to returning value to its...

Continue Reading